Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Understanding the pros and cons of different treatments may help men and their health care teams make more informed treatment decisions.
New drug combos for metastatic breast cancer and a strong focus on toxicities were highlights of the San Antonio Breast Cancer Symposium.
Fertility preservation and assisted reproductive technologies did not worsen outcomes for women with HR-positive breast cancer.
NIH study finds radiation shows strongest association with aging, less for surgery and endocrine treatments.
At least 20 states that have limited gender-affirming treatment for minors.
Americans are uprooting their lives in response to a legislation across the country restricting health care for transgender people.
The daily medication led to improvements in libido, sexual function and overall quality of life.
“Results of the POSITIVE trial confirm pregnancy can be a realistic objective for women who had an estrogen dependent breast cancer.”
The Florida bill also bans hormone therapy, which is used for health issues including menopause, birth control, stunted growth and more.
After 15 years, survival rates were similar for patients who were treated promptly and those who received active monitoring.
Treatment can improve quality of life for people with advanced breast cancer.
Check out these promising breast cancer studies.
Adding an AKT inhibitor to fulvestrant doubled progression-free survival for patients with HR-positive, HER2-negative breast cancer.
Patients whose treatment was guided by measurement of tumor cells in the blood had improved survival outcomes.
Most women who interrupted endocrine therapy were able to conceive, and more than 60% gave birth.
Genomic testing is an important tool to guide treatment decisions among women with early-stage breast cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.